Copyright
©The Author(s) 2015.
World J Gastroenterol. Sep 28, 2015; 21(36): 10367-10374
Published online Sep 28, 2015. doi: 10.3748/wjg.v21.i36.10367
Published online Sep 28, 2015. doi: 10.3748/wjg.v21.i36.10367
Figure 1 Ursodeoxycholic acid suppresses tumor growth in vivo.
A: Tumor volume is plotted as a function of time in days. Tumor volumes plotted represent the median value of xenografts from 10 animals in each group; B: The median value of the tumor volume for each group after 21 d of treatment are graphically depicted. Differences between control and treated xenografts on day 21 reached statistical significance (P < 0.05) at all ursodeoxycholic acid (UDCA) doses (30 mg/kg per day, aP < 0.05; 50 mg/kg per day, bP < 0.05; 70 mg/kg per day, cP < 0.01).
- Citation: Liu H, Xu HW, Zhang YZ, Huang Y, Han GQ, Liang TJ, Wei LL, Qin CY, Qin CK. Ursodeoxycholic acid induces apoptosis in hepatocellular carcinoma xenografts in mice. World J Gastroenterol 2015; 21(36): 10367-10374
- URL: https://www.wjgnet.com/1007-9327/full/v21/i36/10367.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i36.10367